Decoding the Genetic Alterations in Genes of Fibroblast Growth Factor Family and Their  Possible Association with HNSCC

Akshaya, A.; Priyadharsini, J. Vijayashree; Girija, A. S. Smiline; Ganesh, P. Sankar; Poddar, Nidhi

doi:10.9734/jpri/2021/v33i47b33172

Cited by 1 publication

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many studies have confirmed that FGFs are highly expressed in a variety of tumors, such as lung cancer [ 4 , 5 ], gastric cancer [ 6 ], and breast cancer [ 7 ], and promote tumor progression. However, few studies have reported the role of FGFs in cell carcinoma [ 8 ]. Here, we detected FGF3 in 40 cases of tongue squamous cell carcinoma and corresponding adjacent tissues by immunohistochemistry and found high expression levels of FGF3 were 90% in tumors and 12.5% in the surrounding tissues ( P < 0.01).…”

Section: Introductionmentioning

confidence: 99%

Fibroblast Growth Factor 3 Is Associated with Tongue Squamous Cell Carcinoma: A Controlled Study

Zhang

Liu

et al. 2022

Computational and Mathematical Methods in Medicine

View full text Add to dashboard Cite

Objective. To explore the effects of fibroblast growth factor 3 (FGF3) on the proliferation, cell cycle, and apoptosis of the tongue squamous cell carcinoma SCC-9 cell line (SCC-9). Methods. We measured the proliferation of SCC-9 cells in a control group, an FGF3 intervention group, and a fibroblast growth factor (FGFR) inhibitor intervention group in cholecystokinin octapeptide (CCK-8) experiments. We studied effects of FGF3 on the cell cycle and apoptosis of tongue cancer cells using flow cytometry. We further explored the IRS1/PI3K/AKT signaling pathway by measuring BCL-2 and Bcl-2 Associated X-protein (BAX) mRNA and protein levels with RT-PCR and western blot, respectively. Results. Results from the CCK-8 experiment showed that survival rates of cells in the control group, FGF3 intervention group, and FGFR inhibitor intervention group were 100.000 % ± 4.026 % , 136.330 % ± 9.779 %, and 83.199 % ± 4.954 %, respectively; survival rates of SCC-9 cells in all three groups were statistically significant ( P < 0.05 ). Compared with that in the control group, the ratio of cells in G0/G1 phase in the FGFR inhibitor intervention group was higher ( P < 0.05 ) and that in G2/M phase was lower, while the FGF3 intervention group showed opposite results ( P < 0.05 ). The apoptosis rate of tongue cancer cells differed significantly between the FGFR inhibitor intervention and the control groups ( P < 0.05 ). The mRNA and protein expression levels of IRS1, PI3K, and BCL-2 were all increased in the FGF3 intervention group ( P < 0.05 ), while BAX mRNA and protein expression levels were decreased ( P < 0.05 ). The mRNA expression levels of protein kinase B (AKT) showed no differences between groups. The p-AKT protein was overexpressed, while the total amount of AKT protein remained stable ( P < 0.05 ). Conclusion. FGF3 contributes to the proliferation of SCC-9 cells by increasing the proportion of cells in G2/M phase. Therefore, appropriately timed inhibition of FGF3 can potentially promote tumor apoptosis through the IRS1/PI3K/AKT signaling pathway. Our results demonstrate the role of FGF3 in the tumor microenvironment in tongue squamous cell carcinoma SCC-9 cells and suggest new therapeutic targets.

show abstract